口服抗凝剂反应的个体间差异。 - Suppr

Suppr

超能文献

Interindividual differences in the response to oral anticoagulants.

作者信息

Breckenridge A M

出版信息

Drugs. 1977 Nov;14(5):367-75. doi: 10.2165/00003495-197714050-00003.

DOI:10.2165/00003495-197714050-00003

PMID:338281

Abstract

摘要

相似文献

Interindividual differences in the response to oral anticoagulants.

Drugs. 1977 Nov;14(5):367-75. doi: 10.2165/00003495-197714050-00003.

[Disorders of pharmacokinetics in pathological states and their clinical significance].

Pol Tyg Lek. 1984;39(51-52):1681-6.

Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.

Drugs. 1976;11(6):461-70. doi: 10.2165/00003495-197611060-00006.

[Oral anticoagulants: their pharmacology, mechanism of action and therapeutic control].

G Ital Cardiol. 1990 Jul;20(7):653-60.

Novel oral anticoagulants and diet: the potential for interaction.

Am J Hematol. 2009 Apr;84(4):260-1. doi: 10.1002/ajh.21371.

Drug interactions involving oral anticoagulants.

Cardiovasc Clin. 1974;6(2):23-41.

Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants.

Biochem Pharmacol. 1976 May 1;25(9):1063-6. doi: 10.1016/0006-2952(76)90497-4.

[Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].

Arch Int Pharmacodyn Ther. 1974 Apr;208(2):369-72.

The in vivo effects of oral anticoagulants in man: comparison between liver and non-hepatic tissues.

Thromb Haemost. 1988 Apr 8;59(2):147-50.

[Individual variations in the response to drugs in pathological conditions].

Brux Med. 1975 Oct;55(10):519-31.

引用本文的文献

Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

J Pharmacol Exp Ther. 2012 Jan;340(1):46-55. doi: 10.1124/jpet.111.184721. Epub 2011 Oct 4.

Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding.

Clin Pharmacol Ther. 2008 Nov;84(5):581-8. doi: 10.1038/clpt.2008.150. Epub 2008 Aug 6.

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.

Clin Pharmacol Ther. 2008 Sep;84(3):332-9. doi: 10.1038/clpt.2008.101. Epub 2008 Jul 2.

Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.

J Pharmacol Exp Ther. 2008 Jan;324(1):139-48. doi: 10.1124/jpet.107.129858. Epub 2007 Oct 5.

The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

Ir J Med Sci. 1996 Jul-Sep;165(3):213-8. doi: 10.1007/BF02940253.

Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits.

Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):55-60. doi: 10.1007/BF03192289.

Therapeutic control of anticoagulant treatment.

Br Med J (Clin Res Ed). 1982 Mar 6;284(6317):702-4. doi: 10.1136/bmj.284.6317.702.

Attitudes to development of drug therapy in Scandinavia.

Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):19S-26S. doi: 10.1111/j.1365-2125.1986.tb02977.x.

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005.

Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.

Br J Clin Pharmacol. 1987 Nov;24(5):621-5. doi: 10.1111/j.1365-2125.1987.tb03221.x.

本文引用的文献

Effect of sodium dextrothyroxine in patients receiving anticoagulants.

N Engl J Med. 1962 Jan 11;266:76-9. doi: 10.1056/NEJM196201112660205.

Dangers of prolonged anticoagulant therapy in hepatic disease. Diathesis and intercurrent acute hepatitis.

J Am Med Assoc. 1960 Jan 16;172:223-6. doi: 10.1001/jama.1960.03020030017004.

High serum transaminase activity in heart disease. Circulatory failure and hepatic necrosis.

Circulation. 1960 May;21:646-60. doi: 10.1161/01.cir.21.5.646.

RESISTANCE TO WARFARIN IN THE COMMON RAT.

Nature. 1964 Aug 15;203:778. doi: 10.1038/203778a0.

HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.

N Engl J Med. 1964 Oct 15;271:809-15. doi: 10.1056/NEJM196410152711602.

STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: A COMPARISON OF THE PHARMACODYNAMICS OF DICUMAROL AND WARFARIN IN MAN.

Thromb Diath Haemorrh. 1964 Apr 15;11:1-22.

THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER.

Thromb Diath Haemorrh. 1964 Jan 1;10:267-77.

STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.

J Clin Invest. 1963 Oct;42(10):1542-51. doi: 10.1172/JCI104839.

Metabolism of drugs in subjects with Laennec's cirrhosis.

Med Exp Int J Exp Med. 1959;1:290-2. doi: 10.1159/000134806.

The effect of thyroid function on the prothrombin time response to warfarin in rats.

Experientia. 1957 Jun 15;13(6):253-4. doi: 10.1007/BF02157446.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验